High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission

Autor: Hassanein, Mona, Atenafu, Eshetu G., Schuh, Andre C., Yee, Karen W.L., Minden, Mark D., Schimmer, Aaron D., Gupta, Vikas, Brandwein, Joseph M.
Zdroj: In Leukemia Research May 2013 37(5):556-560
Databáze: ScienceDirect
Externí odkaz: